N Plais1, X Thevenot1, A Cogniet1, J Rigal1, J C Le Huec2. 1. Orthospine Department Pr Le Huec JC, Bordeaux University Hospital, 6th Floor, CHU Pellegrin, Place A Raba Leon, 33076, Bordeaux, France. 2. Orthospine Department Pr Le Huec JC, Bordeaux University Hospital, 6th Floor, CHU Pellegrin, Place A Raba Leon, 33076, Bordeaux, France. j-c.lehuec@u-bordeaux.fr.
Abstract
PURPOSE: The treatment of low back pain associated to Disc Degenerative Disease (DDD) is still controversial. Segmental Fusion is the gold standard, but many studies have reported that motion-preserving devices bring substantial clinical benefits to patients. Concerns on the associated complications and on the long-term clinical effectiveness of such instrumentations are still present and have led recently to a decrease of the number of Lumbar Total Disk Replacements (TDR). The objective of this prospective study is to present the clinical and radiographic outcomes of the Maverick Lumbar disk prostheses (Medtronic, TE, Memphis, USA) at long-term follow-up. METHODS: Prospective, single center study of clinical outcome of the treatment with Maverick lumbar Prosthesis of patients with low back pain from DDD resistant to conservative treatment. Patients were examined preoperatively and at 3 months, 2 and 10 years post-operatively. Patients were examined preoperatively and at 3 months, 2 and 10 years post-operatively. Visual analog scale (VAS), Oswestry disability index (ODI) and 36-Item Short Form Health Survey questionnaire were assessed to study clinical outcomes. Radiographic studies allowed measurements of range of motion, adjacent segment disease and pelvic and lumbar parameters. RESULTS: From an initial cohort of 87 patients who underwent TDR between 2003 and 2007 with the Maverick prosthesis, 61 were available at Final follow-up (70%). The clinical outcomes measured by VAS and ODI showed a significant improvement in all the postoperative stages of the follow-up (FU). At 10 years-FU, ODI experienced a mean decrease of 21.1 points, VAS for back pain decreased up to 3.85 and substantial clinical benefit was reached for 55.6% of the patients. Although Mobility of the prosthesis was preserved in 76.8% of the cases, TDR was not clearly protective against ALD. CONCLUSIONS: A significant, clinically relevant, and lasting reduction of back pain has been achieved in patients who underwent a total disk arthroplasty or a Hybrid construct with Maverik prosthesis. TDR is a safe and effective technique to decrease pain in patients with one or two levels of DDD.
PURPOSE: The treatment of low back pain associated to Disc Degenerative Disease (DDD) is still controversial. Segmental Fusion is the gold standard, but many studies have reported that motion-preserving devices bring substantial clinical benefits to patients. Concerns on the associated complications and on the long-term clinical effectiveness of such instrumentations are still present and have led recently to a decrease of the number of Lumbar Total Disk Replacements (TDR). The objective of this prospective study is to present the clinical and radiographic outcomes of the Maverick Lumbar disk prostheses (Medtronic, TE, Memphis, USA) at long-term follow-up. METHODS: Prospective, single center study of clinical outcome of the treatment with Maverick lumbar Prosthesis of patients with low back pain from DDD resistant to conservative treatment. Patients were examined preoperatively and at 3 months, 2 and 10 years post-operatively. Patients were examined preoperatively and at 3 months, 2 and 10 years post-operatively. Visual analog scale (VAS), Oswestry disability index (ODI) and 36-Item Short Form Health Survey questionnaire were assessed to study clinical outcomes. Radiographic studies allowed measurements of range of motion, adjacent segment disease and pelvic and lumbar parameters. RESULTS: From an initial cohort of 87 patients who underwent TDR between 2003 and 2007 with the Maverick prosthesis, 61 were available at Final follow-up (70%). The clinical outcomes measured by VAS and ODI showed a significant improvement in all the postoperative stages of the follow-up (FU). At 10 years-FU, ODI experienced a mean decrease of 21.1 points, VAS for back pain decreased up to 3.85 and substantial clinical benefit was reached for 55.6% of the patients. Although Mobility of the prosthesis was preserved in 76.8% of the cases, TDR was not clearly protective against ALD. CONCLUSIONS: A significant, clinically relevant, and lasting reduction of back pain has been achieved in patients who underwent a total disk arthroplasty or a Hybrid construct with Maverik prosthesis. TDR is a safe and effective technique to decrease pain in patients with one or two levels of DDD.
Entities:
Keywords:
Degenerative disc disease; HRQL; Long term results; Lumbar spine; Total disk replacement
Authors: Stephane Aunoble; Robert Meyrat; Yasser Al Sawad; C Tournier; Philip Leijssen; Jean-Charles Le Huec Journal: Eur Spine J Date: 2009-11-04 Impact factor: 3.134
Authors: Steven D Glassman; Anne G Copay; Sigurd H Berven; David W Polly; Brian R Subach; Leah Y Carreon Journal: J Bone Joint Surg Am Date: 2008-09 Impact factor: 5.284
Authors: Frank J Schwab; Benjamin Blondel; Shay Bess; Richard Hostin; Christopher I Shaffrey; Justin S Smith; Oheneba Boachie-Adjei; Douglas C Burton; Behrooz A Akbarnia; Gregory M Mundis; Christopher P Ames; Khaled Kebaish; Robert A Hart; Jean-Pierre Farcy; Virginie Lafage Journal: Spine (Phila Pa 1976) Date: 2013-06-01 Impact factor: 3.468
Authors: Karin D van den Eerenbeemt; Raymond W Ostelo; Barend J van Royen; Wilco C Peul; Maurits W van Tulder Journal: Eur Spine J Date: 2010-05-28 Impact factor: 3.134
Authors: Roland D Donk; Andre L M Verbeek; Wim I M Verhagen; Hans Groenewoud; Allard T F Hosman; Ronald H M A Bartels Journal: Eur Spine J Date: 2017-08-12 Impact factor: 3.134
Authors: Alisa L Dutmer; Remko Soer; André P Wolff; Michiel F Reneman; Maarten H Coppes; Henrica R Schiphorst Preuper Journal: Eur Spine J Date: 2022-01-19 Impact factor: 3.134